Communiqués Revenio Group Oyj

Actions

REG1V

FI0009010912

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq Helsinki 18:00:00 28/09/2026			Varia. 5j.	Varia. 1 janv.
10,58 ^EUR	-3,29%		-19,60%	-52,77%

23/09	Inderes abaisse l’objectif de cours de Revenio Group à 16,50 euros (19), réitère son conseil à l’achat	FW
15/09	Transcript : Revenio Group Oyj - Analyst/Investor Day

Communiqués

25/09	Revenio Oyj : The Finnish Financial Supervisory Authority has approved the Finnish language prospectus in relation to Revenio Group Corporation's rights offering	PU
25/09	The Finnish Financial Supervisory Authority has approved the Finnish language prospectus in relation to Revenio Group Corporation’s rights offering	AQ
21/09	Managers' transactions - Anat Loewenstein	AQ
21/09	Managers' transactions - Marc Abitbol	AQ
21/09	Managers' transactions - Heli Lindfors	AQ
21/09	Managers' transactions - Bill Östman	AQ
21/09	Managers' transactions - Charles Vilgrain	AQ
21/09	Managers' transactions - Arne Boye Nielsen	AQ
21/09	Managers' transactions - Nicklas Hansen	AQ
21/09	Changes in Revenio Group Corporation's own shares	AQ
21/09	INSIDE INFORMATION: Revenio Group Corporation announces the terms and conditions of its fully underwritten rights offering of approximately EUR 80 million	AQ
15/09	Revenio updates its strategy for 2027–2029 and provides new financial targets for the strategy period	AQ
14/09	Composition of Revenio’s Shareholders’ Nomination Board	AQ
14/09	Revenio Oyj : Composition of Revenio's Shareholders' Nomination Board	PU
10/09	ICare IC1000™: Precision Made Effortless	AQ
08/09	Revenio Group Corporation: Half-Year Report January 1 - June 30, 2026	PU
08/09	Revenio Group Corporation: Half-Year Report January 1 – June 30, 2026	AQ
03/09	Revenio Group – Consensus estimates Q2 2026	AQ
27/08	Revenio Oyj : Half-year report January-June 2026 to be published on September 8, 2026	PU
27/08	Revenio’s Half-year report January-June 2026 to be published on September 8, 2026	AQ
20/08	Revenio Oyj : Invitation to Revenio Group's Capital Markets Day 2026	PU
20/08	Invitation to Revenio Group’s Capital Markets Day 2026	AQ
17/08	Revenio Oyj : iCare DRSplus included in FDA-cleared AI solution for diabetic retinopathy screening	PU
17/08	Revenio’s iCare DRSplus included in FDA-cleared AI solution for diabetic retinopathy screening	AQ
12/08	Jukka Kainulainen starts as Revenio CFO on August 24, 2026	AQ